loader
Please Wait
Applying Filters...
Close
4

SPI Pharma Corp Ad SPI Pharma Corp Ad

X

Annual Sales of pentyl N-{1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-methyloxolan-2-yl]-5-fluoro-2-oxo-1,2-dihydropyrimidin-4-yl}carbamate reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Xeloda (1)

URL Supplier Web Content
Xeloda
Oncology
CHF
1,509
776
-48.60%
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Xeloda
Oncology
CHF
776
513
784
518
-266
-34%
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Xeloda
Oncology
CHF
506
513
501
508
-7
-1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Xeloda
Oncology
CHF
453
506
480
536
-56
-10
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Xeloda
Oncology
CHF
427
453
431
458
-26
-6%
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Xeloda
Oncology
CHF
406
427
418
440
-22
-5
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Xeloda
Oncology
CHF
301
406
335
452
-117
-26
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Xeloda
Oncology
CHF
194
301
209
319
-110
-36
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY